TITLE

Is Vitamin D Deficiency associated with Non Specific Musculoskeletal Pain?

AUTHOR(S)
Abbasi, Mahnaz; Hashemipour, Sima; Hajmanuchehri, Fatemeh; Kazemifar, Amir Mohammad
PUB. DATE
January 2013
SOURCE
Global Journal of Health Science;Jan2013, Vol. 5 Issue 1, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Backgrounds: Vitamin D deficiency is common worldwide, including Iran. It has been suggested that vitamin D deficiency is associated with non-specific musculoskeletal pain. The aim of this study is evaluation of the association of musculoskeletal pain with vitamin D deficiency and the response of the patients to vitamin D supplementation. Materials and Methods: sixty two adult patients with chief complaint of musculoskeletal pain were enrolled in the study. Serum concentrations of 25(OH)D, Calcium, Phosphate, Alkaline Phosphatase and PTH were determined. If there was vitamin D deficiency, oral vitamin D supplementation was given. Assessment of pain and its response to therapy was carried out using Visual Assessment Score (VAS). SPSS software version 15.0 was used for statistical analyses. Findings: Most of the patients (95.4%) had vitamin D deficiency. Pain in 53 patients (85.5%) with responded to the proposed treatment. In responder group post treatment vitamin D concentration was significantly higher than non responder group (60.6±27.6and 39.2±9.6 nmol/l respectively, p<0.01) pretreatment vitamin D and minerals concentrations and pain characteristics did not have significant differences in responder and non responder group. Conclusion: Treatment with vitamin D can relieve the pain in majority of the patients with vitamin D deficiency. Lack of response can be due to insufficient increase in serum vitamin D concentration.Physiologic differences of gastrointestinal vitamin D absorption, differences of body mass indexes, and noncompliance could be potential causes for this issue. Reassessment of serum 25(OH)D concentration is recommended in nonresponsive patients.
ACCESSION #
84959891

 

Related Articles

  • Changes of Biochemical Markers of Bone Turnover in Patients with Graves' Disease. WANG Zhuansuo; SONG Qinhua; WU Yueping; CHEN Hong; TAN Liling; SUN Shenghua // Tianjin Medical Journal;2014, Vol. 42 Issue 7, p683 

    Objective To observe the serum levels of calcium, phosphorus, alkaline phosphatase (ALP), parathyroid hormone (PTH) and 25-hydroxyvitamin D, and the influence of biochemical markers of bone turnover in Graves' disease. Methods Sixty-two patients with Graves' disease were enrolled into the...

  • Prevalence and cut-off point of vitamin D deficiency among secondary students of Arak, Iran in 2010. Talaei, Afsaneh; Yadegari, Nasrin; Rafee, Mohamad; Rezvanfar, Mohamad R.; Moini, Abdolatif // Indian Journal of Endocrinology & Metabolism;Sep2012, Vol. 16 Issue 5, p786 

    Introduction: Vitamin D has a basic role in bone growth and metabolism and has been noticed for its important role in many diseases, such as diabetes, depression, hypertension, and cardiovascular disease. Regarding some studies, detection of vitamin D deficiency in different places has important...

  • VASCULAR CALCIFICATION IN MAINTENANCE HEMODIALYSIS PATIENTS: ARE WE SHOOTING IN THE DARK. Trivedi, H. I. // Indian Journal of Nephrology;Jul-Sep2007, Vol. 17 Issue 3, p123 

    Aim: The aim of the present study was to evaluate the degree of coronary calcification in MHD patients with noninvasive imaging methods and to identify potentially involved factors. Materials and Methods: In this prospective study, we enrolled 15 patients (9 males/6 females, age 35.9±13.54...

  • Association between Serum 25-Hydroxyvitamin D Levels and TTN. Konca, Capan; Kahramaner, Zelal; Bulbul, Mehmet; Erdemir, aydin; Tekin, Mehmet; Ercan, Sumeyye; Yilmaz, Sedat; arpaci, abdullah; Turgut, Mehmet // Hormone Research in Paediatrics;Jul2014, Vol. 81 Issue 6, p397 

    Aim: To investigate the association between serum 25-hydroxyvitamin D (25(OH)D3) levels and transient tachypnea of the newborn (TTN). Methods: Calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), parathormone (PTH) and serum 25(OH)D3 levels were measured in 51 infants diagnosed with TTN and...

  • Vitamin D deficiency in myotonic dystrophy type 1. Terracciano, Chiara; Rastelli, Emanuele; Morello, Maria; Celi, Monica; Bucci, Elisabetta; Antonini, Giovanni; Porzio, Ottavia; Tarantino, Umberto; Zenobi, Rossella; Massa, Roberto // Journal of Neurology;Sep2013, Vol. 260 Issue 9, p2330 

    Myotonic dystrophy type 1 (DM1) is a multisystemic disorder affecting, among others, the endocrine system, with derangement of steroid hormones functions. Vitamin D is a steroid recognized for its role in calcium homeostasis. In addition, vitamin D influences muscle metabolism by genomic and...

  • Significant Association Between Bone-Specific Alkaline Phosphatase and Vascular Calcification of the Hand Arteries in Male Hemodialysis Patients. Ishimura, Eiji; Okuno, Senji; Okazaki, Hisanori; Norimine, Kyoko; Yamakawa, Kenjiro; Yamakawa, Tomoyuki; Shoji, Shigeichi; Nishizawa, Yoshiki; Inaba, Masaaki // Kidney & Blood Pressure Research;Nov2014, Vol. 39 Issue 4, p299 

    Background/Aims: Bone-specific alkaline phosphatase (BAP) hydrolyzes pyrophosphate, which inhibits vascular calcification. We examined association between serum BAP and vascular calcification of male hemodialysis patients. Methods: Hand roentgenography of 167 male maintenance hemodialysis...

  • Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH. Kuragano, Takahiro; Furuta, Minoru; Yahiro, Mana; Kida, Aritoshi; Otaki, Yoshinaga; Hasuike, Yukiko; Matsumoto, Akihide; Nakanishi, Takeshi // BMC Nephrology;2013, Vol. 14 Issue 1, p1 

    Background: Recently, acetate-free citrate containing dialysate (A(-)D) was developed. We have already reported about the significant effect of A(-)D on metabolic acidosis, anemia, and malnutrition in maintenance hemodialysis (MHD) patients. In this study, we compared the effect of A(-)D and...

  • Serum 1-84 and 7-84 parathyroid hormone concentrations and bone in patients with primary hyperparathyroidism. Blachowicz, A.; Chudzinski, W.; Nawrot, I.; Kryszalowicz, B.; Spiechowicz, U.; Szmidt, J.; Wiecek, A.; Franek, E. // Langenbeck's Archives of Surgery;Sep2008, Vol. 393 Issue 5, p709 

    Parathyroid hormone (PTH) acts on bone as both anabolic and catabolic factor. It includes two fractions: 1-84 (cyclase activating PTH, CAP) which increases bone turnover and serum calcium, and 7-84 (cyclase inactivating PTH, CIP) acting the opposite way. The aim of this study was to establish...

  • Manifestaciones musculo-esquelticas en pacientes en hemodilisis cr¢nica. Alca-Clares, Ra£l; Tabori-Peinado, Harold; Calvo-Quiroz, Armando; Berrocal-Kasay, Alfredo; Loza-Munarriz, Cesar // Revista Medica Herediana;oct-dic2013, Vol. 24 Issue 4, p298 

    Objectives: To determine the prevalence of muscle skeletal (MS) manifestations in patients on chronic hemodialysis (CH). Methods: Case series that included 68 patients with at least 18 years of age on CH for at least 6 months in the Hemodialysis Centre of Cayetano Heredia University. Demographic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics